IBDEI073 ; ; 18-NOV-2013
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;NOV 18, 2013
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,9276,2)
 ;;=Pinguecula^265525
 ;;^UTILITY(U,$J,358.3,9277,0)
 ;;=379.00^^63^611^40
 ;;^UTILITY(U,$J,358.3,9277,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9277,1,3,0)
 ;;=3^Episcleritis
 ;;^UTILITY(U,$J,358.3,9277,1,4,0)
 ;;=4^379.00
 ;;^UTILITY(U,$J,358.3,9277,2)
 ;;=...^108564
 ;;^UTILITY(U,$J,358.3,9278,0)
 ;;=372.40^^63^611^104
 ;;^UTILITY(U,$J,358.3,9278,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9278,1,3,0)
 ;;=3^Pterygium
 ;;^UTILITY(U,$J,358.3,9278,1,4,0)
 ;;=4^372.40
 ;;^UTILITY(U,$J,358.3,9278,2)
 ;;=Pterygium^100819
 ;;^UTILITY(U,$J,358.3,9279,0)
 ;;=694.4^^63^611^96
 ;;^UTILITY(U,$J,358.3,9279,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9279,1,3,0)
 ;;=3^Pemphigus
 ;;^UTILITY(U,$J,358.3,9279,1,4,0)
 ;;=4^694.4
 ;;^UTILITY(U,$J,358.3,9279,2)
 ;;=Pemphigus^91124
 ;;^UTILITY(U,$J,358.3,9280,0)
 ;;=224.3^^63^611^10
 ;;^UTILITY(U,$J,358.3,9280,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9280,1,3,0)
 ;;=3^Benign Neopl Conjunctiva
 ;;^UTILITY(U,$J,358.3,9280,1,4,0)
 ;;=4^224.3
 ;;^UTILITY(U,$J,358.3,9280,2)
 ;;=Benign Neoplasm Conjunctiva^267673
 ;;^UTILITY(U,$J,358.3,9281,0)
 ;;=370.40^^63^611^67
 ;;^UTILITY(U,$J,358.3,9281,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9281,1,3,0)
 ;;=3^Keratoconjunctivitis
 ;;^UTILITY(U,$J,358.3,9281,1,4,0)
 ;;=4^370.40
 ;;^UTILITY(U,$J,358.3,9281,2)
 ;;=^66777
 ;;^UTILITY(U,$J,358.3,9282,0)
 ;;=694.5^^63^611^95
 ;;^UTILITY(U,$J,358.3,9282,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9282,1,3,0)
 ;;=3^Pemphigoid
 ;;^UTILITY(U,$J,358.3,9282,1,4,0)
 ;;=4^694.5
 ;;^UTILITY(U,$J,358.3,9282,2)
 ;;=Pemphigoid^91108
 ;;^UTILITY(U,$J,358.3,9283,0)
 ;;=364.10^^63^611^54
 ;;^UTILITY(U,$J,358.3,9283,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9283,1,3,0)
 ;;=3^Iridocyclitis, Chronic
 ;;^UTILITY(U,$J,358.3,9283,1,4,0)
 ;;=4^364.10
 ;;^UTILITY(U,$J,358.3,9283,2)
 ;;=Iridocyclitis, Chronic^24398
 ;;^UTILITY(U,$J,358.3,9284,0)
 ;;=054.44^^63^611^55
 ;;^UTILITY(U,$J,358.3,9284,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9284,1,3,0)
 ;;=3^Iridocyclitis, H Simplex
 ;;^UTILITY(U,$J,358.3,9284,1,4,0)
 ;;=4^054.44
 ;;^UTILITY(U,$J,358.3,9284,2)
 ;;=Iridocyclitis, H Simplex^266565
 ;;^UTILITY(U,$J,358.3,9285,0)
 ;;=053.22^^63^611^56
 ;;^UTILITY(U,$J,358.3,9285,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9285,1,3,0)
 ;;=3^Iridocyclitis, H Zoster
 ;;^UTILITY(U,$J,358.3,9285,1,4,0)
 ;;=4^053.22
 ;;^UTILITY(U,$J,358.3,9285,2)
 ;;=Iridocyclitis, H Zoster^266554
 ;;^UTILITY(U,$J,358.3,9286,0)
 ;;=364.42^^63^611^111
 ;;^UTILITY(U,$J,358.3,9286,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9286,1,3,0)
 ;;=3^Rubeosis Iridis
 ;;^UTILITY(U,$J,358.3,9286,1,4,0)
 ;;=4^364.42
 ;;^UTILITY(U,$J,358.3,9286,2)
 ;;=Rubeosis Iridis^268716
 ;;^UTILITY(U,$J,358.3,9287,0)
 ;;=364.59^^63^611^59
 ;;^UTILITY(U,$J,358.3,9287,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9287,1,3,0)
 ;;=3^Iris Atrophy,Other
 ;;^UTILITY(U,$J,358.3,9287,1,4,0)
 ;;=4^364.59
 ;;^UTILITY(U,$J,358.3,9287,2)
 ;;=Iris Atrophy^268731
 ;;^UTILITY(U,$J,358.3,9288,0)
 ;;=224.0^^63^611^11
 ;;^UTILITY(U,$J,358.3,9288,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9288,1,3,0)
 ;;=3^Benign Neopl of Iris
 ;;^UTILITY(U,$J,358.3,9288,1,4,0)
 ;;=4^224.0
 ;;^UTILITY(U,$J,358.3,9288,2)
 ;;=^267670
 ;;^UTILITY(U,$J,358.3,9289,0)
 ;;=364.72^^63^611^6
 ;;^UTILITY(U,$J,358.3,9289,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9289,1,3,0)
 ;;=3^Anterior Synechiae
 ;;^UTILITY(U,$J,358.3,9289,1,4,0)
 ;;=4^364.72
 ;;^UTILITY(U,$J,358.3,9289,2)
 ;;=Anterior Synechiae^265517
 ;;^UTILITY(U,$J,358.3,9290,0)
 ;;=364.71^^63^611^102
 ;;^UTILITY(U,$J,358.3,9290,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9290,1,3,0)
 ;;=3^Posterior Synechiae
 ;;^UTILITY(U,$J,358.3,9290,1,4,0)
 ;;=4^364.71
 ;;^UTILITY(U,$J,358.3,9290,2)
 ;;=Posterior Synechiae^265519
 ;;^UTILITY(U,$J,358.3,9291,0)
 ;;=364.00^^63^611^57
 ;;^UTILITY(U,$J,358.3,9291,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9291,1,3,0)
 ;;=3^Iridocyclitis,Acute/Subacute,Unspec
 ;;^UTILITY(U,$J,358.3,9291,1,4,0)
 ;;=4^364.00
 ;;^UTILITY(U,$J,358.3,9291,2)
 ;;=Iridocyclitis, Acute^268703
 ;;^UTILITY(U,$J,358.3,9292,0)
 ;;=379.40^^63^611^106
 ;;^UTILITY(U,$J,358.3,9292,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9292,1,3,0)
 ;;=3^Pupil, Abnormal function
 ;;^UTILITY(U,$J,358.3,9292,1,4,0)
 ;;=4^379.40
 ;;^UTILITY(U,$J,358.3,9292,2)
 ;;=Pupil, Abnormal function^101288
 ;;^UTILITY(U,$J,358.3,9293,0)
 ;;=190.0^^63^611^84
 ;;^UTILITY(U,$J,358.3,9293,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9293,1,3,0)
 ;;=3^Malig Neopl of Eyeball,Iris
 ;;^UTILITY(U,$J,358.3,9293,1,4,0)
 ;;=4^190.0
 ;;^UTILITY(U,$J,358.3,9293,2)
 ;;=Malig Neopl of Iris^267271
 ;;^UTILITY(U,$J,358.3,9294,0)
 ;;=190.3^^63^611^83
 ;;^UTILITY(U,$J,358.3,9294,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9294,1,3,0)
 ;;=3^Malig Neopl Conjunctiva
 ;;^UTILITY(U,$J,358.3,9294,1,4,0)
 ;;=4^190.3
 ;;^UTILITY(U,$J,358.3,9294,2)
 ;;=Malig Neopl Conjunctiva^267274
 ;;^UTILITY(U,$J,358.3,9295,0)
 ;;=364.41^^63^611^50
 ;;^UTILITY(U,$J,358.3,9295,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9295,1,3,0)
 ;;=3^Hyphema
 ;;^UTILITY(U,$J,358.3,9295,1,4,0)
 ;;=4^364.41
 ;;^UTILITY(U,$J,358.3,9295,2)
 ;;=Hyphema^60498
 ;;^UTILITY(U,$J,358.3,9296,0)
 ;;=364.05^^63^611^51
 ;;^UTILITY(U,$J,358.3,9296,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9296,1,3,0)
 ;;=3^Hypopyon
 ;;^UTILITY(U,$J,358.3,9296,1,4,0)
 ;;=4^364.05
 ;;^UTILITY(U,$J,358.3,9296,2)
 ;;=Hypopion^60720
 ;;^UTILITY(U,$J,358.3,9297,0)
 ;;=365.02^^63^611^4
 ;;^UTILITY(U,$J,358.3,9297,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9297,1,3,0)
 ;;=3^Angle, Narrow
 ;;^UTILITY(U,$J,358.3,9297,1,4,0)
 ;;=4^365.02
 ;;^UTILITY(U,$J,358.3,9297,2)
 ;;=Angle, Narrow^268748
 ;;^UTILITY(U,$J,358.3,9298,0)
 ;;=372.63^^63^611^117
 ;;^UTILITY(U,$J,358.3,9298,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9298,1,3,0)
 ;;=3^Symblepharon
 ;;^UTILITY(U,$J,358.3,9298,1,4,0)
 ;;=4^372.63
 ;;^UTILITY(U,$J,358.3,9298,2)
 ;;=Symblepharon^265885
 ;;^UTILITY(U,$J,358.3,9299,0)
 ;;=372.75^^63^611^27
 ;;^UTILITY(U,$J,358.3,9299,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9299,1,3,0)
 ;;=3^Cysts, Conjunctival
 ;;^UTILITY(U,$J,358.3,9299,1,4,0)
 ;;=4^372.75
 ;;^UTILITY(U,$J,358.3,9299,2)
 ;;=Cysts, Conjunctival^269049
 ;;^UTILITY(U,$J,358.3,9300,0)
 ;;=364.81^^63^611^43
 ;;^UTILITY(U,$J,358.3,9300,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9300,1,3,0)
 ;;=3^Floppy Iris Syndrome
 ;;^UTILITY(U,$J,358.3,9300,1,4,0)
 ;;=4^364.81
 ;;^UTILITY(U,$J,358.3,9300,2)
 ;;=^335254
 ;;^UTILITY(U,$J,358.3,9301,0)
 ;;=006.9^^63^611^2
 ;;^UTILITY(U,$J,358.3,9301,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9301,1,3,0)
 ;;=3^Amebiasis
 ;;^UTILITY(U,$J,358.3,9301,1,4,0)
 ;;=4^006.9
 ;;^UTILITY(U,$J,358.3,9301,2)
 ;;=^5818
 ;;^UTILITY(U,$J,358.3,9302,0)
 ;;=190.8^^63^611^60
 ;;^UTILITY(U,$J,358.3,9302,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9302,1,3,0)
 ;;=3^Iris Melanoma,Contiguous Site
 ;;^UTILITY(U,$J,358.3,9302,1,4,0)
 ;;=4^190.8
 ;;^UTILITY(U,$J,358.3,9302,2)
 ;;=^267278
 ;;^UTILITY(U,$J,358.3,9303,0)
 ;;=224.1^^63^611^93
 ;;^UTILITY(U,$J,358.3,9303,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9303,1,3,0)
 ;;=3^Orbit Neoplasm,Benign
 ;;^UTILITY(U,$J,358.3,9303,1,4,0)
 ;;=4^224.1
 ;;^UTILITY(U,$J,358.3,9303,2)
 ;;=^267671
 ;;^UTILITY(U,$J,358.3,9304,0)
 ;;=360.33^^63^611^52
 ;;^UTILITY(U,$J,358.3,9304,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9304,1,3,0)
 ;;=3^Hypotony,Assoc w/ Ocular D/O
 ;;^UTILITY(U,$J,358.3,9304,1,4,0)
 ;;=4^360.33
 ;;^UTILITY(U,$J,358.3,9304,2)
 ;;=^268560
 ;;^UTILITY(U,$J,358.3,9305,0)
 ;;=224.8^^63^611^86
 ;;^UTILITY(U,$J,358.3,9305,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9305,1,3,0)
 ;;=3^Neopl Eye Bgn,Oth Iris Nevus
 ;;^UTILITY(U,$J,358.3,9305,1,4,0)
 ;;=4^224.8
 ;;^UTILITY(U,$J,358.3,9305,2)
 ;;=^267678
 ;;^UTILITY(U,$J,358.3,9306,0)
 ;;=364.01^^63^611^103
 ;;^UTILITY(U,$J,358.3,9306,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9306,1,3,0)
 ;;=3^Prim Iridocyclitis
 ;;^UTILITY(U,$J,358.3,9306,1,4,0)
 ;;=4^364.01
 ;;^UTILITY(U,$J,358.3,9306,2)
 ;;=^268704
 ;;^UTILITY(U,$J,358.3,9307,0)
 ;;=364.04^^63^611^53
 ;;^UTILITY(U,$J,358.3,9307,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9307,1,3,0)
 ;;=3^Iridociclyties 2ary,Non Infectious
 ;;^UTILITY(U,$J,358.3,9307,1,4,0)
 ;;=4^364.04
 ;;^UTILITY(U,$J,358.3,9307,2)
 ;;=^268710
 ;;^UTILITY(U,$J,358.3,9308,0)
 ;;=364.21^^63^611^46
 ;;^UTILITY(U,$J,358.3,9308,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9308,1,3,0)
 ;;=3^Fuch's Hetero Cyclitis
 ;;^UTILITY(U,$J,358.3,9308,1,4,0)
 ;;=4^364.21
 ;;^UTILITY(U,$J,358.3,9308,2)
 ;;=^48468
 ;;^UTILITY(U,$J,358.3,9309,0)
 ;;=364.23^^63^611^81
 ;;^UTILITY(U,$J,358.3,9309,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9309,1,3,0)
 ;;=3^Lens-Induced Iridocyclitis
 ;;^UTILITY(U,$J,358.3,9309,1,4,0)
 ;;=4^364.23
 ;;^UTILITY(U,$J,358.3,9309,2)
 ;;=^268713
 ;;^UTILITY(U,$J,358.3,9310,0)
 ;;=364.51^^63^611^8
 ;;^UTILITY(U,$J,358.3,9310,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9310,1,3,0)
 ;;=3^Atrophy Iris Essential/Progressive
 ;;^UTILITY(U,$J,358.3,9310,1,4,0)
 ;;=4^364.51
 ;;^UTILITY(U,$J,358.3,9310,2)
 ;;=^268718
 ;;^UTILITY(U,$J,358.3,9311,0)
 ;;=364.53^^63^611^100
 ;;^UTILITY(U,$J,358.3,9311,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9311,1,3,0)
 ;;=3^Pigment Dispersion w/o Glauc
 ;;^UTILITY(U,$J,358.3,9311,1,4,0)
 ;;=4^364.53
 ;;^UTILITY(U,$J,358.3,9311,2)
 ;;=^268720
 ;;^UTILITY(U,$J,358.3,9312,0)
 ;;=364.57^^63^611^33
 ;;^UTILITY(U,$J,358.3,9312,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9312,1,3,0)
 ;;=3^Degen Ciliary Body Changes
 ;;^UTILITY(U,$J,358.3,9312,1,4,0)
 ;;=4^364.57
 ;;^UTILITY(U,$J,358.3,9312,2)
 ;;=^268728
 ;;^UTILITY(U,$J,358.3,9313,0)
 ;;=364.60^^63^611^26
 ;;^UTILITY(U,$J,358.3,9313,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9313,1,3,0)
 ;;=3^Cyst,Idiopathic
 ;;^UTILITY(U,$J,358.3,9313,1,4,0)
 ;;=4^364.60
